RxDoctor Payments Data

Lisa Roberts

Family · Big Flats, NYNPI 1750558086

Payments from drug & device makers

$8,028in general payments, 2019–2025

Across 142 payments — averaging $56.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Spinal Simplicity, LLC$2K
  • SPR Therapeutics, Inc$676
  • Collegium Pharmaceutical, Inc.$586
  • Johnson & Johnson$253
  • E.r. Squibb & Sons, L.L.C.$243
  • plus $1K from 18 others

What the payments were for

  • Travel & lodging$2,12526%
  • Food & beverage$4,45055%
  • Education$1,45318%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,028 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate31$21,815
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen333$13,059
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen421$12,701
Fentanyl38$6,770
LinzessLinaclotide12$6,438
OxycontinOxycodone Hcl15$5,986
Oxycodone Hcl122$3,266
Gabapentin225$3,008
Hydromorphone Hcl123$2,782
Pregabalin91$2,549
Cyclobenzaprine Hcl192$1,893
Lidocaine19$1,459
Celecoxib48$1,170
Tizanidine Hcl98$1,127
Duloxetine Hcl52$974

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$586$21,81531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.

Other family in Big Flats

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →